G-CSF Mobilized CD34+ Cells in Transplant
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-Cells
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 120 patients (estimated)
- Sponsors
- National Heart, Lung, and Blood Institute (NHLBI)
- Tags
- Allogeneic Stem Cell Transplant, CD34
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1580
- NCT Identifier
- NCT01174108
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.